Literature DB >> 3704168

Antinociception opioids and the cholinergic system.

P G Green, I Kitchen.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 3704168     DOI: 10.1016/0301-0082(86)90002-x

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


× No keyword cloud information.
  7 in total

1.  Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice.

Authors:  J Gomeza; L Zhang; E Kostenis; C Felder; F Bymaster; J Brodkin; H Shannon; B Xia; C Deng; J Wess
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  The effects of cholinoceptor agonists and antagonists on C-fibre evoked responses in the substantia gelatinosa of neonatal rat spinal cord slices.

Authors:  L Bleazard; R Morris
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

3.  Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice.

Authors:  J Gomeza; H Shannon; E Kostenis; C Felder; L Zhang; J Brodkin; A Grinberg; H Sheng; J Wess
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

4.  Muscarinic excitatory and inhibitory mechanisms involved in afferent fibre-evoked depolarization of motoneurones in the neonatal rat spinal cord.

Authors:  T Kurihara; H Suzuki; M Yanagisawa; K Yoshioka
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

Review 5.  Roles of the hippocampal formation in pain information processing.

Authors:  Ming-Gang Liu; Jun Chen
Journal:  Neurosci Bull       Date:  2009-10       Impact factor: 5.203

6.  Diazepam enhances fentanyl and diminishes meperidine antinociception.

Authors:  S A Bergman; R L Wyn; G Williams
Journal:  Anesth Prog       Date:  1988 Sep-Oct

Review 7.  Interactive Mechanisms of Supraspinal Sites of Opioid Analgesic Action: A Festschrift to Dr. Gavril W. Pasternak.

Authors:  Grace C Rossi; Richard J Bodnar
Journal:  Cell Mol Neurobiol       Date:  2020-09-24       Impact factor: 5.046

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.